Anaphylaxis: Recognition and management

American Family Physician

Volumn 84, Issue 10, 2011, Pages 1111-1118

  Arnold, James J ^a   Williams, Pamela M ^a  

^a DAVID GRANT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALLERGEN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; MONOAMINE OXIDASE INHIBITOR; OXYGEN; RECOMBINANT GLUCAGON; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUTE DISEASE; AGITATION; AIRWAY OBSTRUCTION; ALGORITHM; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIGEN SPECIFICITY; ANXIETY; ARTICLE; BASOPHIL; CARDIOVASCULAR DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DRUG DOSAGE FORM COMPARISON; DRUG INDUCED HEADACHE; DRUG MECHANISM; ERYTHEMA; FOOD ALLERGY; GASTROINTESTINAL DISEASE; HEART PALPITATION; HUMAN; HYPOTENSION; IMMUNE RESPONSE; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; LABORATORY TEST; MAST CELL; MEDICAL CARE; NEUROLOGIC DISEASE; PALLOR; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PREDICTION; PRESCRIPTION; PRURITUS; RECOMMENDED DRUG DOSE; RECURRENCE RISK; RESPIRATORY FAILURE; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; SKIN MANIFESTATION; SKIN TEST; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; URTICARIA;

EID: 81355153559     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma, and Immunology; Joint Council on Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter [published correction appears in J Allergy Clin Immunol. 2008; 122(1): 68]. J Allergy Clin Immunol. 2005; 115(3 suppl 2): S483-S523.
2. Tang ML, Osborne N, Allen K. Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol. 2009; 9(4): 351-356.
3. Kemp SF. Navigating the updated anaphylaxis parameters. Allergy Asthma Clin Immunol. 2007; 3(2): 40-49.
4. González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LA. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol. 2010; 125(5): 1098-1104.
5. Simons FE. Anaphylaxis [published correction appears in J Allergy Clin Immunol. 2010; 126(4): 885]. J Allergy Clin Immunol. 2010; 125(2 suppl 2): S161-S181.
6. Ben-Shoshan M, Clark AE. Anaphylaxis: past, present and future. Allergy. 2011; 66(1): 1-14.
7. Worth A, Soar J, Sheikh A. Management of anaphylaxis in the emergency setting. Expert Rev Clin Immunol. 2010; 6(1): 89-100.
8. Kemp SF. The post-anaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms? Curr Allergy Asthma Rep. 2008; 8(1): 45-48.
9. Oswalt ML, Kemp SF. Anaphylaxis: office management and prevention. Immunol Allergy Clin North Am. 2007; 27(2): 177-191, vi.
10. Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second Symposium on the Definition and Management of Anaphylaxis: summary report-second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. Ann Emerg Med. 2006; 47(4): 373-380.
11. Stone SF, Cotterell C, Isbister GK, Holdgate A, Brown SG; Emergency Department Anaphylaxis Investigators. Elevated serum cytokines during human anaphylaxis: identification of potential mediators of acute allergic reactions. J Allergy Clin Immunol. 2009; 124(4): 786-792. e4.
12. Kemp SF. Office approach to anaphylaxis: sooner better than later. Am J Med. 2007; 120(8): 664-668.
13. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics. 2003; 111(6 pt 3): 1601-1608.
14. Russell S, Monroe K, Losek JD. Anaphylaxis management in the pediatric emergency department: opportunities for improvement. Pediatr Emerg Care. 2010; 26(2): 71-76.
15. Nurmatov U, Worth A, Sheikh A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol. 2008; 122(2): 353-361. e1-e3.
16. Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for ananphylaxis. A statement of the World Allergy Organization. Allergy. 2008; 63(8): 1061-1070.
17. McLean-Tooke AP, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ. 2003; 327(7427): 1332-1335.
18. Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2009; 64(2): 204-212.
19. Simons FE. Pharmacologic treatment of anaphylaxis: can the evidence base be strengthened? Curr Opin Allergy Clin Immunol. 2010; 10(4): 384-393.
20. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992; 327(6): 380-384.
21. Wheeler DW, Carter JJ, Murray LJ, et al. The effect of drug concentration expression on epinephrine dosing errors: a randomized trial. Ann Intern Med. 2008; 148(1): 11-14.
22. Sicherer SH, Simons FE; Section on Allergy and Immunology, American Academy of Pediatrics. Self-injectable epinephrine for first-aid management of anaphylaxis [published correction appears in Pediatrics. 2007; 119(6): 1271]. Pediatrics. 2007; 119(3): 638-646.
23. Baker TW, Stolfi A, Johnson TL. Use of epinephrine autoinjectors for treatment of anaphylaxis: which commercially available autoinjector do patients prefer? Ann Allergy Asthma Immunol. 2009; 103(4): 356-358.
24. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007; 62(8): 830-837.
25. Choo KJ, Simons FE, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev. 2010; (3): CD007596.
26. Mrvos R, Anderson BD, Krenzelok EP. Accidental injection of epinephrine from an autoinjector: invasive treatment not always required. South Med J. 2002; 95(3): 318-320.
27. Simons FE, Lieberman PL, Read EJ Jr, Edwards ES. Hazards of unintentional injection of epinephrine from autoinjectors: a systematic review. Ann Allergy Asthma Immunol. 2009; 102(4): 282-287.
28. Simons FE, Edwards ES, Read EJ Jr, Clark SC, Liebelt EL. Voluntarily reported unintentional injections from epinephrine auto-injectors. J Allergy Clin Immunol. 2010; 125(2): 419-423. e4.
29. Epipen [package insert]. Columbia, Md.: Meridian Medical Technologies; 2008. http://www.epipen.com/how-to-use-epipen. Accessed July 15, 2011.